Healthcare provider profile · identity verified

Parth Jitendra Patel, DO

Internal Medicine · SYRACUSE, NY · NPI 1689168791

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	561	111
Levothyroxine Sodium	Levothyroxine Sodium	320	60
Pantoprazole Sodium	Pantoprazole Sodium	308	65
Eliquis	Apixaban	263	33
Gabapentin	Gabapentin	242	41
Amlodipine Besylate	Amlodipine Besylate	231	40
Lisinopril	Lisinopril	225	56
Metoprolol Succinate	Metoprolol Succinate	190	38
Losartan Potassium	Losartan Potassium	166	41
Metformin Hcl	Metformin Hcl	166	39
Baclofen	Baclofen	161	27
Bumetanide	Bumetanide	159	33
Famotidine	Famotidine	158	29
Omeprazole	Omeprazole	154	30
Meloxicam	Meloxicam	147	33
Albuterol Sulfate Hfa	Albuterol Sulfate	143	52
Escitalopram Oxalate	Escitalopram Oxalate	127	22
Simvastatin	Simvastatin	120	21
Rosuvastatin Calcium	Rosuvastatin Calcium	110	28
Sertraline Hcl	Sertraline Hcl	106	18
Trazodone Hcl	Trazodone Hcl	103	16
Clopidogrel	Clopidogrel Bisulfate	93	20
Mirtazapine	Mirtazapine	91	16
Metoprolol Tartrate	Metoprolol Tartrate	89	19
Myrbetriq	Mirabegron	82	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	81	13
Albuterol Sulfate	Albuterol Sulfate	79	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	77	26
Latanoprost	Latanoprost	77	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	77	14
Donepezil Hcl	Donepezil Hcl	76	suppressed
Potassium Chloride	Potassium Chloride	76	12
Fenofibrate	Fenofibrate	75	11
Quetiapine Fumarate	Quetiapine Fumarate	69	suppressed
Risperidone	Risperidone	69	11
Allopurinol	Allopurinol	66	14
Spironolactone	Spironolactone	62	11
Duloxetine Hcl	Duloxetine Hcl	61	15
Tramadol Hcl	Tramadol Hcl	60	suppressed
Alendronate Sodium	Alendronate Sodium	59	13
Vitamin D2	Ergocalciferol (Vitamin D2)	57	15
Furosemide	Furosemide	56	19
Atenolol	Atenolol	54	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	54	12
Montelukast Sodium	Montelukast Sodium	53	14
Levetiracetam	Levetiracetam	51	suppressed
Pregabalin	Pregabalin	51	suppressed
Nystatin	Nystatin	50	24
Hydrochlorothiazide	Hydrochlorothiazide	48	16
Ezetimibe	Ezetimibe	47	suppressed
Tizanidine Hcl	Tizanidine Hcl	44	16
Atrovent Hfa	Ipratropium Bromide	42	suppressed
Doxepin Hcl	Doxepin Hcl	42	suppressed
Glimepiride	Glimepiride	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	42	16
Symbicort	Budesonide/Formoterol Fumarate	42	suppressed
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Tradjenta	Linagliptin	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	22
Buspirone Hcl	Buspirone Hcl	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	12
Methocarbamol	Methocarbamol	36	14
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Irbesartan	Irbesartan	34	suppressed
Midodrine Hcl	Midodrine Hcl	33	suppressed
Torsemide	Torsemide	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Cephalexin	Cephalexin	29	16
Nuedexta	Dextromethorphan Hbr/Quinidine	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Budesonide	Budesonide	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Divalproex Sodium Er	Divalproex Sodium	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	23	23
Chlorthalidone	Chlorthalidone	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Finasteride	Finasteride	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Sotalol	Sotalol Hcl	21	suppressed
Creon	Lipase/Protease/Amylase	20	suppressed
Ozempic	Semaglutide	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Loperamide	Loperamide Hcl	18	13
Ondansetron Odt	Ondansetron	18	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Metolazone	Metolazone	17	suppressed
Ramelteon	Ramelteon	17	suppressed
Roflumilast	Roflumilast	17	suppressed
Atropine Sulfate	Atropine Sulfate	16	suppressed
Combigan	Brimonidine Tartrate/Timolol	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Azithromycin	Azithromycin	14	12
Carbamazepine	Carbamazepine	14	suppressed
Digoxin	Digoxin	14	suppressed
Methylprednisolone	Methylprednisolone	14	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Clonidine	Clonidine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Ramipril	Ramipril	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Isoniazid	Isoniazid	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Olanzapine	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error